CB2 is primarily expressed in the immune cells and tissues of the body. Like CB1, CB2 is a G protein-coupled receptor which inhibits adenylyl cyclase and consequently lowers cAMP upon activation. This, in turn, regulates many second messenger pathways.

CBDA is a precursor of CBD (obtained by decarboxylation of CBDA) that has physiological and therapeutic properties of its own right.